Abstract:PURPOSE Recurrence is the leading cause of death in hepatocellular carcinoma (HCC) patients with curative resection. In this study, we aimed to develop a preoperative predictive model based on high-throughput radiomics features and clinical factors for prediction of long- and short-term recurrence for these patients. METHODS A total of 270 patients with HCC who were followed up for at least 5 years after curative hepatectomy between June 2014 and December 2017 were enrolled in this retrospective study. Regions of interest (ROIs) were manually delineated in preoperative T2-weighted images using ITK-SNAP software on each HCC tumor slice. A total of 1197 radiomics features were extracted and the recursive feature elimination method based on logistic regression was used for radiomics signature building. 10-fold cross-validation was applied for model development. Nomogram were constructed and assessed by calibration plot, which compares nomogram-predicated probability with observed outcome. Receiver-operating characteristic was then generated to evaluate the predictive performance of the model in the development and test cohorts. RESULTS The 10 most recurrence-free survival related radiomics features were selected for the radiomics signatures. A multiparametric clinical-radiomics model combining albumin and Radiomics score (Rad-score) for recurrence prediction was further established. The integrated model demonstrated good calibration and satisfactory discrimination, with the AUC of 0.864, 95% CI 0.842-0.903, sensitivity of 0.889 and specificity of 0.644 in the test set. Calibration curve showed good agreement concerning 5-year recurrence risk predicted by the nomogram. In addition, the AUC of 1, 2, 3 and 4-year recurrence was 0.935 (95% CI, 0.836-1.000), 0.861 (95% CI, 0.723-0.999), 0.878 (95% CI, 0.762-0.994) and 0.878 (95% CI, 0.762-0.994) in the test set, respective. CONCLUSIONS The clinical-radiomics model integrating radiomic features and clinical factors can improve recurrence predictions beyond predictions made using clinical factors or radiomic features alone. Our clinical-radiomics model is a valid method to predict recurrence that should improve preoperative prognostic performance and allow more individualized treatment decisions. This article is protected by copyright. All rights reserved.

Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma after Surgical Resection

Deep Learning-Based Radiomics Models for Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images and Clinical Data.

Gadoxetic Acid-Enhanced MRI Radiomics Signature: Prediction of Clinical Outcome in Hepatocellular Carcinoma after Surgical Resection.

Radiomics-based Machine Learning to Predict the Recurrence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging

A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma

Radiomics analysis of gadoxetic acid-enhanced MRI for evaluating vessels encapsulating tumour clusters in hepatocellular carcinoma

MRI-based Radiomics Model for Preoperative Prediction of 5-Year Survival in Patients with Hepatocellular Carcinoma.

Hepatocellular Carcinoma: Radiomics Nomogram on Gadoxetic Acid-Enhanced MR Imaging for Early Postoperative Recurrence Prediction

A MRI-based Radiomics Model for Preoperative Prediction of Five-Year Survival Status in Hepatocellular Carcinoma.

Radiomics Analysis Enables Recurrence Prediction for Hepatocellular Carcinoma after Liver Transplantation

Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma

Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence‐Free Survival in Hepatocellular Carcinoma

Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study

Development of a magnetic resonance imaging-derived radiomics model to predict microvascular invasion in patients with hepatocellular carcinoma

Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma

A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma

Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence

Development and validation of a clinic-radiomic model to predict recurrence for patients with hepatocellular carcinoma after curative resection.

Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection